PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26693911-0	2016	Dexamethasone Inhibits TGF-beta1-Induced Cell Migration by Regulating the ERK and AKT Pathways in Human Colon Cancer Cells Via CYR61.	Dexamethasone	0-13	AKT serine/threonine kinase 1	Homo sapiens	82-85	
26693911-7	2016	Alternatively, both migratory pathways, expression of AKT and ERK, and the target factor CYR61 was also tested by co-treatment with TGF-beta1 and dexamethasone.	Dexamethasone	146-159	AKT serine/threonine kinase 1	Homo sapiens	54-57	
26693911-10	2016	ERK and AKT signaling pathways were found to mediate TGF-beta1-induced migration, which was inhibited by dexamethasone.	Dexamethasone	105-118	AKT serine/threonine kinase 1	Homo sapiens	8-11	
26693911-14	2016	CONCLUSION: These findings suggested that dexamethasone inhibits AKT and ERK phosphorylation, leading to decreased CYR61 expression, which in turn blocks TGF-beta1-induced migration.	Dexamethasone	42-55	AKT serine/threonine kinase 1	Homo sapiens	65-68